Call Options Transactions Made in Q3 2024 in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR) during Q3 2024. The information is specifically focused on institutions that hold call options of Esperion Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Prelude Capital Management, LLC
New York, NY |
BUY
|
CALL |
34.8KNew |
$56K - $95K
|
34.8K
$64.7K
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
34.4KNew |
$55.4K - $93.9K
|
34.4K
$64K
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
31.6K+ 76.89% |
$50.9K - $86.3K
|
72.7K
$135K
|
|
Nov 14, 2024
Q3 2024
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
CALL |
4K+ 30.77% |
$6.44K - $10.9K
|
17K
$31.6K
|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-10.2K- 35.54% |
$16.4K - $27.8K
|
18.5K
$34.4K
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
SELL
|
CALL |
-40.9K- 79.26% |
$65.8K - $112K
|
10.7K
$19.9K
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-703K- 75.18% |
$1.13M - $1.92M
|
232K
$432K
|